Login / Signup

The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study.

Alison K YoderDavid S LakomyYongquan DongSuchismita RaychaudhuryKathryn RoyseChristine HartmanPeter RichardsonDonna L WhiteJennifer R KramerLilie L LinElizabeth Yu Chiao
Published in: BMC cancer (2021)
The use of protease inhibitors during chemoradiation for anal carcinoma was not associated with any clinical outcome or increase in non-hematologic toxicity. Their use was associated with increased hospitalizations for hematologic toxicities. Further prospective research is needed to evaluate the safety and efficacy of protease inhibitors for patients undergoing chemoradiation.
Keyphrases
  • locally advanced
  • rectal cancer
  • patients undergoing
  • high grade
  • squamous cell carcinoma
  • papillary thyroid
  • oxidative stress
  • radiation therapy
  • squamous cell
  • metabolic syndrome
  • lymph node metastasis
  • childhood cancer